VAXX vs. BRK-B

In the year-to-date period, VAXX achieves a -98.00% return, which is significantly lower than BRK-B's 11.67% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Vaxxinity, Inc. (VAXX) and Berkshire Hathaway Inc. (BRK-B). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current VAXX Sharpe Ratio is -0.00, which is lower than the BRK-B Sharpe Ratio of 1.29. The chart below compares the historical Sharpe Ratios of VAXX and BRK-B, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither VAXX nor BRK-B has paid dividends to shareholders.

The maximum VAXX drawdown since its inception was -100.00%, which is greater than BRK-B's maximum drawdown of -53.86%. Use the drawdown chart below to compare losses from any high point for VAXX and BRK-B.

Vaxxinity, Inc. (VAXX) has a higher volatility of 836.72% compared to Berkshire Hathaway Inc. (BRK-B) at 6.63%. This indicates that VAXX's price experiences larger fluctuations and is considered to be riskier than BRK-B based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Vaxxinity, Inc. and Berkshire Hathaway Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.